SZTURZ, Petr, Zdeněk ADAM, Z. ŘEHÁK and Renata KOUKALOVÁ. Xanthelasma palpebrarum responding to interleukin-1 blockade. Internal medicine journal. Hoboken: Wiley-Blackwell, 2014, vol. 44, No 6, p. 617-618. ISSN 1444-0903. Available from: https://dx.doi.org/10.1111/imj.12441.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Xanthelasma palpebrarum responding to interleukin-1 blockade
Authors SZTURZ, Petr (203 Czech Republic, guarantor, belonging to the institution), Zdeněk ADAM (203 Czech Republic, belonging to the institution), Z. ŘEHÁK (203 Czech Republic) and Renata KOUKALOVÁ (203 Czech Republic).
Edition Internal medicine journal, Hoboken, Wiley-Blackwell, 2014, 1444-0903.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.644
RIV identification code RIV/00216224:14110/14:00076145
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/imj.12441
UT WoS 000337966800018
Keywords in English xanthelasma palpebrarum; Erdheim–Chester disease; anakinra
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 29/11/2016 15:03.
Abstract
Darstein et al. presented an interesting case of a 45-yearold man diagnosed with Erdheim–Chester disease (ECD), a rare non-Langerhans cell histiocytosis characterised by proliferation and accumulation of lipid laden foamy histiocytes. Subsequently, the patient was successfully treated with combination of anakinra (interleukin-1 receptor antagonist) and glucocorticoids.1 We draw readers’ attention to xanthelasma palpebrarum as a common manifestation of ECD.
PrintDisplayed: 27/5/2024 16:35